scholarly journals A Mobile Technology for Collecting Patient-Reported Physical Activity and Distress Outcomes: Cross-Sectional Cohort Study

10.2196/17320 ◽  
2020 ◽  
Vol 8 (5) ◽  
pp. e17320
Author(s):  
Miyeon Jung ◽  
SaeByul Lee ◽  
Jisun Kim ◽  
HeeJeong Kim ◽  
BeomSeok Ko ◽  
...  

Background Electronic patient-reported outcome (PROs) provides a fast and reliable assessment of a patient’s health-related quality of life. Nevertheless, using PRO in the traditional paper format is not practical for clinical practice due to the limitations associated with data analysis and management. A questionnaire app was developed to address the need for a practical way to group and use distress and physical activity assessment tools. Objective The purpose of this study was to assess the level of agreement between electronic (mobile) and paper-and-pencil questionnaire responses. Methods We validated the app version of the distress thermometer (DT), International Physical Activity Questionnaire (IPAQ), and Patient Health Questionnaire–9 (PHQ-9). A total of 102 participants answered the paper and app versions of the DT and IPAQ, and 96 people completed the PHQ-9. The study outcomes were the correlation of the data between the paper-and-pencil and app versions. Results A total of 106 consecutive breast cancer patients were enrolled and analyzed for validation of paper and electronic (app) versions. The Spearman correlation values of paper and app surveys for patients who responded to the DT questionnaire within 7 days, within 3 days, and on the same day were .415 (P<.001), .437 (P<.001), and .603 (P<.001), respectively. Similarly, the paper and app survey correlation values of the IPAQ total physical activity metabolic equivalent of task (MET; Q2-6) were .291 (P=.003), .324 (P=.005), and .427 (P=.01), respectively. The correlation of the sum of the Patient Health Questionnaire–9 (Q1-9) according to the time interval between the paper-based questionnaire and the app-based questionnaire was .469 for 14 days (P<.001), .574 for 7 days (P<.001), .593 for 3 days (P<.001), and .512 for the same day (P=.03). These were all statistically significant. Similarly, the correlation of the PHQ (Q10) value according to the time interval between the paper-based questionnaire and the app-based questionnaire was .283 for 14 days (P=.005), .409 for 7 days (P=.001), .415 for 3 days (P=.009), and .736 for the same day (P=.001). These were all statistically significant. In the overall trend, the shorter the interval between the paper-and-pencil questionnaire and the app-based questionnaire, the higher the correlation value. Conclusions The app version of the distress and physical activity questionnaires has shown validity and a high level of association with the paper-based DT, IPAQ (Q2-6), and PHQ-9. The app-based questionnaires were not inferior to their respective paper versions and confirm the feasibility for their use in clinical practice. The high correlation between paper and mobile app data allows the use of new mobile apps to benefit the overall health care system. Trial Registration ClinicalTrials.gov NCT03072966; https://clinicaltrials.gov/ct2/show/NCT03072966

2019 ◽  
Author(s):  
Miyeon Jung ◽  
SaeByul Lee ◽  
Jisun Kim ◽  
HeeJeong Kim ◽  
BeomSeok Ko ◽  
...  

BACKGROUND Electronic patient-reported outcome (PROs) provides a fast and reliable assessment of a patient’s health-related quality of life. Nevertheless, using PRO in the traditional paper format is not practical for clinical practice due to the limitations associated with data analysis and management. A questionnaire app was developed to address the need for a practical way to group and use distress and physical activity assessment tools. OBJECTIVE The purpose of this study was to assess the level of agreement between electronic (mobile) and paper-and-pencil questionnaire responses. METHODS We validated the app version of the distress thermometer (DT), International Physical Activity Questionnaire (IPAQ), and Patient Health Questionnaire–9 (PHQ-9). A total of 102 participants answered the paper and app versions of the DT and IPAQ, and 96 people completed the PHQ-9. The study outcomes were the correlation of the data between the paper-and-pencil and app versions. RESULTS A total of 106 consecutive breast cancer patients were enrolled and analyzed for validation of paper and electronic (app) versions. The Spearman correlation values of paper and app surveys for patients who responded to the DT questionnaire within 7 days, within 3 days, and on the same day were .415 (<i>P</i>&lt;.001), .437 (<i>P</i>&lt;.001), and .603 (<i>P</i>&lt;.001), respectively. Similarly, the paper and app survey correlation values of the IPAQ total physical activity metabolic equivalent of task (MET; Q2-6) were .291 (<i>P</i>=.003), .324 (<i>P</i>=.005), and .427 (<i>P</i>=.01), respectively. The correlation of the sum of the Patient Health Questionnaire–9 (Q1-9) according to the time interval between the paper-based questionnaire and the app-based questionnaire was .469 for 14 days (<i>P</i>&lt;.001), .574 for 7 days (<i>P</i>&lt;.001), .593 for 3 days (<i>P</i>&lt;.001), and .512 for the same day (<i>P</i>=.03). These were all statistically significant. Similarly, the correlation of the PHQ (Q10) value according to the time interval between the paper-based questionnaire and the app-based questionnaire was .283 for 14 days (<i>P</i>=.005), .409 for 7 days (<i>P</i>=.001), .415 for 3 days (<i>P</i>=.009), and .736 for the same day (<i>P</i>=.001). These were all statistically significant. In the overall trend, the shorter the interval between the paper-and-pencil questionnaire and the app-based questionnaire, the higher the correlation value. CONCLUSIONS The app version of the distress and physical activity questionnaires has shown validity and a high level of association with the paper-based DT, IPAQ (Q2-6), and PHQ-9. The app-based questionnaires were not inferior to their respective paper versions and confirm the feasibility for their use in clinical practice. The high correlation between paper and mobile app data allows the use of new mobile apps to benefit the overall health care system. CLINICALTRIAL ClinicalTrials.gov NCT03072966; https://clinicaltrials.gov/ct2/show/NCT03072966


2018 ◽  
Vol 18 (8) ◽  
pp. 1398-1405 ◽  
Author(s):  
Andrew N. Tuck ◽  
Melissa B. Scribani ◽  
Scott D. Grainger ◽  
Celeste A. Johns ◽  
Reginald Q. Knight

2021 ◽  
Author(s):  
Tomer Yona ◽  
Asaf Weisman ◽  
Uri Gottlieb ◽  
Eshed Lin ◽  
Youssef Masharawi

Objective: To assess the psychometric properties of the Hebrew version of the Patient Health Questionnaire (PHQ-9) in the general population. Methods: Using an online survey, we assessed test-retest reliability with a two-week time interval. A total of 118 participants enrolled in the study, of whom 103 completed the survey twice. Each participant filled out the PHQ-9 and the 12-Item Short Form Survey (SF-12). Our statistical analysis includes Cronbachs alpha, Intraclass Correlation Coefficient (ICC2,1), Spearmans rank correlation coefficient, Standard Error of Measurement (SEM), and Minimal Detectable Change (MDC). Results: Internal consistency of the Hebrew version of the PHQ-9 ranged from alpha=0.79-0.83. The test-retest reliability of the questionnaire is good (ICC2,1= 0.81), and it is moderately and negatively correlated to the mental component of the SF-12 (Spearman rho;= -0.57, p< .05). The SEM of the PHQ-9 is 1.83 points, and the MDC was found to be 5 points. Conclusion: The Hebrew version of the PHQ-9 is valid and reliable for screening self-reported depressive symptoms online in the general Hebrew-speaking population.


2018 ◽  
Author(s):  
Sarah Patrick ◽  
Peter Connick

AbstractBackgroundDepression affects approximately 25% of people with MS (pwMS) at any given time. It is however under recognised in clinical practice, in part due to a lack of uptake for brief assessment tools and uncertainty about their psychometric properties. The 9-item Patient Health Questionnaire (PHQ-9) is an attractive candidate for this role.ObjectiveTo synthesise published findings on the psychometric properties of the 9-item Patient Health Questionnaire (PHQ-9) when applied to people with multiple sclerosis (pwMS).Data sourcesPubMed, Medline and ISI Web of Science databases, supplemented by hand-searching of references from all eligible sources.Study eligibility criteriaPrimary literature written in English and published following peer-review with a primary aim to evaluate the performance of the PHQ-9 in pwMS.Outcome measuresPsychometric performance with respect to appropriateness, reliability, validity, responsiveness, precision, interpretability, acceptability, and feasibility.ResultsSeven relevant studies were identified, these were of high quality and included 5080 participants from all MS disease-course groups. Strong evidence was found supporting the validity of the PHQ-9 as a unidimensional measure of depression. Used as a screening tool for major depressive disorder (MDD) with a cut-point of 11, sensitivity was 95% sensitivity and specificity 88.3% (PPV 51.4%, NPV 48.6%). Alternative scoring systems that may address the issue of overlap between somatic features of depression and features of MS per se are being developed, although their utility remains unclear. However data on reliability was limited, and no specific evidence was available on test-retest reliability, responsiveness, acceptability, or feasibility.ConclusionsThe PHQ-9 represents a suitable tool to screen for MDD in pwMS. However use as a diagnostic tool cannot currently be recommended, and the potential value for monitoring depressive symptoms cannot be established without further evidence on test-retest reliability, responsiveness, acceptability, and feasibility.PROSPERO register ID: CRD42017067814


2020 ◽  
Vol 52 (1-2) ◽  
pp. 67-72
Author(s):  
Milutin Kostić ◽  
Ana Munjiza ◽  
Ana Jakoviljević

Scales for assessment of patients with depression are in use for several decades. Among the most used are Hamilton's depression scale and the younger Patient Health Questionnaire. Even though both are heavily used in research and clinical practice they are still controversial and with questionable usefulness. This case report shows that the question whether a patient is better or worse can be diametrically opposite depending on the scale used (using these two most influential ones as examples) and what are the reasons for this.


Author(s):  
Sylvia E. Badon ◽  
Esti Iturralde ◽  
Linda Nkemere ◽  
Nerissa Nance ◽  
Lyndsay A. Avalos

Background: Physical activity (PA) can help reduce depression symptom severity in women with perinatal depression. However, PA is low, and barriers and motivators for PA among women with perinatal depression are not well understood. Methods: An ethnically diverse sample of women with perinatal depression was identified using a universal perinatal depression screening program. The authors conducted 8 focus groups (4 in pregnant women [n = 15] and 4 in postpartum women [n = 20]). Depression symptoms were measured using the Patient Health Questionnaire-8 at recruitment. Focus groups were analyzed using an inductive approach. Results: Pregnant participants were 27 weeks gestation, and postpartum participants were 11.5 months postpartum, on average. Depression symptoms were moderately severe (mean Patient Health Questionnaire-8 score: 16). Women identified practical barriers and motivators for PA common to perinatal women (physical health, parental responsibilities, PA tracking tools, and environmental factors) and described emotional and social factors influencing PA. Motivators included using PA to improve mood, relieve stress, boost self-image, and spend time with others. Bad mood, fear of social judgment, and feeling discouraged made it difficult to be active. Conclusion: PA interventions in women with perinatal depression should include components addressing emotional and social barriers to PA in addition to addressing additional common practical barriers to PA.


Thorax ◽  
2018 ◽  
Vol 74 (1) ◽  
pp. 33-42 ◽  
Author(s):  
Christopher E Cox ◽  
Catherine L Hough ◽  
Derek M Jones ◽  
Anna Ungar ◽  
Wen Reagan ◽  
...  

BackgroundPatients who are sick enough to be admitted to an intensive care unit (ICU) commonly experience symptoms of psychological distress after discharge, yet few effective therapies have been applied to meet their needs.MethodsPilot randomised clinical trial with 3-month follow-up conducted at two academic medical centres. Adult (≥18 years) ICU patients treated for cardiorespiratory failure were randomised after discharge home to 1 of 3 month-long interventions: a self-directed mobile app-based mindfulness programme; a therapist-led telephone-based mindfulness programme; or a web-based critical illness education programme.ResultsAmong 80 patients allocated to mobile mindfulness (n=31), telephone mindfulness (n=31) or education (n=18), 66 (83%) completed the study. For the primary outcomes, target benchmarks were exceeded by observed rates for all participants for feasibility (consent 74%, randomisation 91%, retention 83%), acceptability (mean Client Satisfaction Questionnaire 27.6 (SD 3.8)) and usability (mean Systems Usability Score 89.1 (SD 11.5)). For secondary outcomes, mean values (and 95% CIs) reflected clinically significant group-based changes on the Patient Health Questionnaire depression scale (mobile (−4.8 (−6.6, −2.9)), telephone (−3.9 (−5.6, −2.2)), education (−3.0 (−5.3, 0.8)); the Generalized Anxiety Disorder scale (mobile −2.1 (−3.7, −0.5), telephone −1.6 (−3.0, −0.1), education −0.6 (−2.5, 1.3)); the Post-Traumatic Stress Scale (mobile −2.6 (−6.3, 1.2), telephone −2.2 (−5.6, 1.2), education −3.5 (−8.0, 1.0)); and the Patient Health Questionnaire physical symptom scale (mobile −5.3 (−7.0, −3.7), telephone −3.7 (−5.2, 2.2), education −4.8 (−6.8, 2.7)).ConclusionsAmong ICU patients, a mobile mindfulness app initiated after hospital discharge demonstrated evidence of feasibility, acceptability and usability and had a similar impact on psychological distress and physical symptoms as a therapist-led programme. A larger trial is warranted to formally test the efficacy of this approach.Trial registration numberResults, NCT02701361.


2021 ◽  
Vol 3 ◽  
Author(s):  
Kathryn E. Coakley ◽  
David T. Lardier ◽  
Kelley R. Holladay ◽  
Fabiano T. Amorim ◽  
Micah N. Zuhl

Background: The coronavirus disease 2019 (COVID-19) pandemic placed social, travel, school access, and learning restrictions on University students. Excessive restriction measures have been shown to have negative impacts on mental health. Physical activity preserves mental health, and may be useful during quarantines.Purpose: Explore physical activity and sedentary behavior and associations with depression and anxiety symptoms among University students during COVID-19 restrictions in the Fall 2020 semester.Methods: Six hundred and ninety-seven undergraduates (18–25 years) from a U.S. public University completed a cross-sectional survey in fall 2020. The survey included demographic questions, the Generalized Anxiety Disorder Scale 7 (GAD-7), the Patient Health Questionnaire 9 (PHQ-9), and questions about meeting moderate to vigorous physical activity (MVPA) recommendations and sedentary behavior.Results: Forty-nine percent did not meet MVPA guidelines. Patient Health Questionnaire 9 (p = 0.002) and GAD-7 (p = 0.024) scores were higher among those who did not achieve MVPA. Sitting time (h/day) was a significant associated with depression (B = 0.29 (0.06), p &lt; 0.05, 95% CI = 0.18, 0.41) and anxiety (B = 0.24 (0.05), p &lt; 0.05, 95% CI = 0.13, 0.34) severity.Conclusion: Physical activity was associated with mental health among University students during COVID-19 lockdowns.


2020 ◽  
Vol 15 (12) ◽  
pp. 1785-1795
Author(s):  
Karli Kondo ◽  
Jennifer R. Antick ◽  
Chelsea K. Ayers ◽  
Devan Kansagara ◽  
Pavan Chopra

Background and objectivesPatients with kidney failure experience depression at rates higher than the general population. Despite the Centers for Medicare and Medicaid Services’ ESRD Quality Incentive Program requirements for routine depression screening for patients with kidney failure, no clear guidance exists.Design, setting, participants, & measurementsFor this systematic review, we searched MEDLINE, PsycINFO, and other databases from inception to June 2020. Two investigators screened all abstracts and full text. We included studies assessing patients with kidney failure and compared a tool to a clinical interview or another validated tool (e.g., Beck Depression Inventory II). We abstracted data related to sensitivity and specificity, positive and negative predictive value, and the area under the curve. We evaluated the risk of bias using the Quality Assessment of Diagnostic Accuracy Studies 2.ResultsA total of 16 studies evaluated the performance characteristics of depression assessment tools for patients with kidney failure. The Beck Depression Inventory II was by far the best studied. A wide range of thresholds were reported. Shorter tools in the public domain such as the Patient Health Questionnaire 9 and Geriatric Depression Scale 15 (adults over 60) performed well but were not well studied. Short tools such as the Beck Depression Inventory–Fast Screen may be a good option for an initial screen.ConclusionsThere is limited research evaluating the diagnostic accuracy of most screening tools for depression in patients with kidney failure, and existing studies may not be generalizable to US populations. Studies suffer from limitations related to methodology quality and/or reporting. Future research should target widely used, free tools such as the Patient Health Questionnaire 2 and the Patient Health Questionnaire 9.Clinical Trial registry name and registration number:Systematic Review Registration: PROSPERO CRD42020140227.


Sign in / Sign up

Export Citation Format

Share Document